Ocular surgeries are steadily shifting away from hospitals, a move that offers convenience and financial perks. But questions of safety and accessibility remain.
An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
A study drug safely minimizes severity for those with a painful eye condition, a new clinical trial at the University of Michigan Kellogg Eye Center has found.
A study including more than 4,000 people with either type 1 or type 2 diabetes — all under age 21 — revealed a troubling eye health trend.
Why do so many people, especially young adults, seek emergency care for mundane eye complaints? Researchers highlight the trend — and better options.